Healthcare leaders are under constant pressure to make decisions based on evidence, especially when it comes to preventing healthcare-associated infections (HAIs). But not all evidence is created equal. The way a study is designed and how its data is analyzed can dramatically influence how much confidence we should place in its results. Specifically, when infection prevention research uses Bayesian statistics, the result is a fundamentally different (and often more practical) way of interpreting data compared to traditional approaches. Understanding why this matters can help clinicians and administrators better evaluate new technologies.
Most clinical studies you encounter rely on what’s called frequentist statistics. This is the traditional framework behind p-values and statements like:
While widely used, this approach has a limitation: It doesn't really directly prove that the intervention caused the change, but rather, if any measured change could be explained through chance alone. "What are the chances we would get this result if the intervention did not have any effect?"
Let's consider infection prevention. Healthcare associated infections (HAIs0 are influenced by dozens of variables:
A study might show no “statistically significant” reduction in infections, even if the intervention actually helped, especially if the many other factors that influence HAIs were present. Or it might show significance when, in fact, the change was due to something other than the intervention but was not taken into consideration. For example, if a hospital was measuring the efficacy of a new hand hygiene program but did not take into consideration the Hawthorne effect.
Bayesian statistics takes a different approach. Instead of asking: “Was the change due to something rather than chance?” It asks: “Given everything we know, how likely is it that this intervention works,and by how much?” The results are a lot more practical and helpful.
How does this statistics model accomplish this feat? In short, the statistical model learns.
Instead of a yes/no answer, you get something like:
That’s far more aligned with how clinicians actually think and make decisions.
|
An Analogy: The Umbrella As the frequentist, you step outside and look at the sky for a moment, and say: “Based on this snapshot, I cannot conclude it is raining.” That may technically be correct, but it ignores everything else you know: The forecast predicted rain, the air feels humid, you saw dark clouds earlier. As the Bayesian, you combine all available information: The forecast says 70% chance of rain, the sky is dark, it’s rained the last three afternoons. You conclude: “There’s a high probability it will rain. I’ll bring an umbrella.” This is exactly what Bayesian statistics does in medicine. It builds on prior knowledge. It learns. |
Infection prevention is inherently complex and probabilistic. It's about managing risk across dynamic systems. Bayesian methods are particularly well-suited because they:
Some healthcare decisions are more clear cut than others: Does the medication work? Does this therapy improve patient outcomes? However, when complex systems and relationships exist, they must be examined in a way that can accommodate all those factors. Bayesian statistics represents a shift toward painting a more complete picture of the situation, leading to more informed decision-making.
For infection prevention professionals tasked with protecting patients in complex environments, understanding the different statistical models they will encounter in peer-reviewed research is important. As new studies emerge evaluating interventions like biocidal surfaces, it’s worth paying close attention not just to what the results say, but how those results were generated.